These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24736184)

  • 1. Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.
    Riaño Barros DA; McGinnity CJ; Rosso L; Heckemann RA; Howes OD; Brooks DJ; Duncan JS; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2014 Aug; 97():151-62. PubMed ID: 24736184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reproducibility of quantitative binding measures of [
    McGinnity CJ; Riaño Barros DA; Rosso L; Veronese M; Rizzo G; Bertoldo A; Hinz R; Turkheimer FE; Koepp MJ; Hammers A
    Neuroimage; 2017 May; 152():270-282. PubMed ID: 28292717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands.
    Terry GE; Hirvonen J; Liow JS; Zoghbi SS; Gladding R; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Donohue SR; Pike VW; Halldin C; Innis RB
    J Nucl Med; 2010 Jan; 51(1):112-20. PubMed ID: 20008988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.
    Terry GE; Liow JS; Zoghbi SS; Hirvonen J; Farris AG; Lerner A; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Hong JS; Pike VW; Halldin C; Innis RB
    Neuroimage; 2009 Nov; 48(2):362-70. PubMed ID: 19573609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain.
    Yasuno F; Brown AK; Zoghbi SS; Krushinski JH; Chernet E; Tauscher J; Schaus JM; Phebus LA; Chesterfield AK; Felder CC; Gladding RL; Hong J; Halldin C; Pike VW; Innis RB
    Neuropsychopharmacology; 2008 Jan; 33(2):259-69. PubMed ID: 17392732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling [
    Laurencin C; Lancelot S; Gobert F; Redouté J; Mérida I; Iecker T; Liger F; Irace Z; Greusard E; Lamberet L; Bars DL; Costes N; Ballanger B
    Neuroimage; 2021 Oct; 240():118328. PubMed ID: 34224852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine test-retest data.
    Hammers A; Asselin MC; Turkheimer FE; Hinz R; Osman S; Hotton G; Brooks DJ; Duncan JS; Koepp MJ
    Neuroimage; 2007 Oct; 38(1):82-94. PubMed ID: 17764977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
    Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
    Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography.
    Terry GE; Hirvonen J; Liow JS; Seneca N; Tauscher JT; Schaus JM; Phebus L; Felder CC; Morse CL; Pike VW; Halldin C; Innis RB
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1499-506. PubMed ID: 20333514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.
    Terry G; Liow JS; Chernet E; Zoghbi SS; Phebus L; Felder CC; Tauscher J; Schaus JM; Pike VW; Halldin C; Innis RB
    Neuroimage; 2008 Jul; 41(3):690-8. PubMed ID: 18456516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors.
    Tsujikawa T; Zoghbi SS; Hong J; Donohue SR; Jenko KJ; Gladding RL; Halldin C; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Jan; 84():733-41. PubMed ID: 24076222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
    Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences.
    Normandin MD; Zheng MQ; Lin KS; Mason NS; Lin SF; Ropchan J; Labaree D; Henry S; Williams WA; Carson RE; Neumeister A; Huang Y
    J Cereb Blood Flow Metab; 2015 Aug; 35(8):1313-22. PubMed ID: 25833345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
    Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
    Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.
    Wong DF; Kuwabara H; Horti AG; Raymont V; Brasic J; Guevara M; Ye W; Dannals RF; Ravert HT; Nandi A; Rahmim A; Ming JE; Grachev I; Roy C; Cascella N
    Neuroimage; 2010 Oct; 52(4):1505-13. PubMed ID: 20406692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
    Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
    Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.